INT Medical Reports No Share Capital Changes for May 2026; Confirms Sufficient Public Float

Bulletin Express06-01

Shanghai INT Medical Instruments Co., Ltd. filed its monthly return for the period ended 31 May 2026, showing no movements in authorised or issued share capital during the month.

Total issued share capital remained at RMB 211.20 million, divided into 139.41 million H shares and 71.79 million domestic shares, all with a par value of RMB 1. Both categories recorded zero increases or reductions versus April.

The issuer held no treasury shares, and the total number of issued H shares and domestic shares was unchanged at 139.41 million and 71.79 million, respectively.

INT Medical confirmed compliance with Hong Kong Main Board Rule 13.32D(1), stating that the minimum 25% public-float requirement for its H shares is satisfied.

No share options, warrants, convertible securities, HDRs, or other equity-linked instruments were outstanding or issued in May. The board further certified full adherence to all listing rules and regulatory obligations associated with its capital structure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment